Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTA 402 in Advanced Malignant Melanoma
NCT00535314Phase 2Withdrawn
- Sponsor
- Biogen
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of bardoxolone methyl in Malignant Melanoma (MM), sponsored by Biogen. Status: withdrawn.
02
Drugs
bardoxolone methyl
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00535314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535314.